跳至主要内容
临床试验/NCT01855984
NCT01855984已完成2 期

Tocotrienols Supplementation in School Going Children With Attention Deficit/Hyperactivity Disorder(ADHD) - A Randomized Controlled Trial

RCSI & UCD Malaysia Campus2 个研究点 分布在 1 个国家目标入组 160 人开始时间: 2012年2月1日最近更新:
适应症

试验速览

阶段
2 期
状态
已完成
发起方
入组人数
160
试验地点
2
主要终点
ADHD symptom scores as measured by NICHQ Vanderbilt Parent and Teacher Assessment Scales

研究概览

简要总结

The purpose of this study is to determine if tocotrienol supplementation given to school going children with ADHD will result in reduction of their ADHD symptoms.

详细描述

The main objective of the study is to:

a. Determine if supplementation of tocotrienol compared to placebo has an effect on the symptoms of school going children with ADHD.

The secondary objective is to:

  1. Determine if supplementation of tocotrienol compared to placebo has an effect on the dose of current medication used in school going children with ADHD.
  2. Determine the safety of tocotrienol in the study population.
  3. Determine if tocotrienol levels in children with ADHD correlate with their symptom scores.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)

入排标准

年龄范围
6 Years 至 12 Years(Child)
性别
All
接受健康志愿者

入选标准

  • Diagnosed with ADHD in accordance with the Diagnostic and Statistical Manual (DSM) IV criteria.
  • Be able to swallow soft gel capsules.
  • If already on medication for ADHD, the dose of the medication must be stable for the last 3months
  • Be able to attend all follow up visits.
  • Be agreeable to have their teacher score the National Initiative for Children's Healthcare Quality (NICHQ) Vanderbilt Assessment Scale - Teacher Informant
  • Be willing to have their blood taken 3 times during the study.

排除标准

  • ADHD caused by syndromes, inborn errors of metabolism, or structural brain lesions.
  • Co-existing chronic liver disease
  • Current use of anticoagulant or antiplatelet drugs.

结局指标

主要结局

ADHD symptom scores as measured by NICHQ Vanderbilt Parent and Teacher Assessment Scales

时间窗: Change of total symptom scores from baseline at 6 months

次要结局

  • Change in the dose of current medication for ADHD(After 6 months intervention)
  • Number of participants with adverse reaction(6 months)
  • Blood tocotrienol levels(6 months)

研究者

发起方
RCSI & UCD Malaysia Campus
申办方类型
Other
责任方
Principal Investigator
主要研究者

May Loong Tan

Dr

RCSI & UCD Malaysia Campus

研究点 (2)

Loading locations...

相似试验

Tocotrienols for School-going Children With ADHD | 临床试验